Peng Huang’s team developed a biomimetic nanoemulsion expressing PD-1 on its cell membrane, which is used for synergetic photodynamic immunotherapy against hypoxic breast cancer, the treatments inhibit tumor growth by promoting dendritic cell maturation and tumor infiltration by cytotoxic T lymphocytes. Here, PDCD1 is linked to neoplasm.